X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (38) 38
index medicus (32) 32
chemotherapy (30) 30
humans (29) 29
cancer (20) 20
female (20) 20
lung cancer (20) 20
male (18) 18
adult (17) 17
middle aged (17) 17
performing operations (17) 17
transporting (17) 17
cancer therapies (15) 15
optics (15) 15
patients (15) 15
aged (14) 14
lung cancer, non-small cell (14) 14
prognosis (14) 14
removable external protective coverings specially adapted forvehicles (14) 14
vehicles in general (14) 14
windows, windscreens, non-fixed roofs, doors, or similardevices for vehicles (14) 14
fixed constructions (13) 13
medical prognosis (13) 13
neoplasms. tumors. oncology. including cancer and carcinogens (13) 13
non-small cell lung cancer (12) 12
original research (12) 12
care and treatment (11) 11
clinical trials (11) 11
keys (11) 11
locks (11) 11
metastasis (11) 11
physics (11) 11
safes (11) 11
studies (11) 11
window or door fittings (11) 11
treatment outcome (10) 10
tumors (10) 10
vehicles, vehicle fittings, or vehicle parts, not otherwiseprovided for (10) 10
accessories therefor (9) 9
docetaxel (9) 9
genetic aspects (9) 9
handcuffs (9) 9
lung neoplasms - drug therapy (9) 9
lung neoplasms - pathology (9) 9
research (9) 9
survival (9) 9
young adult (9) 9
analysis (8) 8
biotechnology & applied microbiology (8) 8
carcinoma, non-small-cell lung - drug therapy (8) 8
cisplatin (8) 8
neoplasm staging (8) 8
oncotargets and therapy (8) 8
phase-iii trial (8) 8
checks for wings (7) 7
devices for moving wings into open or closed position (7) 7
drug therapy (7) 7
gefitinib (7) 7
hospitals (7) 7
wing fittings not otherwise provided for, concerned with thefunctioning of the wing (7) 7
adenocarcinoma (6) 6
cancer research (6) 6
carcinoma, non-small-cell lung - pathology (6) 6
health aspects (6) 6
hematology (6) 6
immunotherapy (6) 6
lymphocytes (6) 6
nuclear physics (6) 6
adolescent (5) 5
antineoplastic agents - therapeutic use (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
arrangement of signalling or lighting devices, the mounting orsupporting thereof or circuits therefor, for vehicles ingeneral (5) 5
bevacizumab (5) 5
epidermal growth factor (5) 5
expression (5) 5
gemcitabine (5) 5
light (5) 5
melanoma (5) 5
methods (5) 5
multicenter (5) 5
neoplasm metastasis (5) 5
optical elements, systems, or apparatus (5) 5
original (5) 5
patient outcomes (5) 5
pemetrexed (5) 5
pharmacology & pharmacy (5) 5
quality of life (5) 5
review (5) 5
risk factors (5) 5
survival rate (5) 5
toxicity (5) 5
tyrosine (5) 5
animals (4) 4
anlotinib (4) 4
antigens (4) 4
apoptosis (4) 4
biochemistry & molecular biology (4) 4
biomarkers, tumor - metabolism (4) 4
breast cancer (4) 4
carcinoma (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 13, pp. 1448 - 1454
Journal Article
Investigational New Drugs, ISSN 0167-6997, 4/2018, Volume 36, Issue 2, pp. 315 - 322
Background Dulanermin is a recombinant soluble human Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) that activates apoptotic... 
Dulanermin | Objective response rate | Phase III | Medicine & Public Health | NSCLC | Oncology | Pharmacology/Toxicology | Progression-free survival | CARBOPLATIN | TRAIL | BEVACIZUMAB | HUMAN APO2L/TRAIL | COMBINATION | CHEMOTHERAPY | PACLITAXEL | ONCOLOGY | PHARMACOLOGY & PHARMACY | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - drug therapy | Vinorelbine - adverse effects | Humans | Middle Aged | Kaplan-Meier Estimate | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Treatment Outcome | TNF-Related Apoptosis-Inducing Ligand - therapeutic use | TNF-Related Apoptosis-Inducing Ligand - adverse effects | Young Adult | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Cisplatin - adverse effects | Vinorelbine - therapeutic use | Adult | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Complications and side effects | Dosage and administration | Genetic aspects | Research | Lung cancer, Non-small cell | Drug therapy | Cisplatin | Slopes | Leukopenia | Toxicity | Lung cancer | Survival | Patients | Studies | Chemotherapy | Experimental design | Tumor necrosis factor | Quality | Safety engineering | Ligands | Tumor necrosis factor-TNF | TRAIL protein | Toxic diseases | Safety | Vinorelbine | Cancer | Apoptosis | Neutropenia | Recombinant | Index Medicus
Journal Article
Journal Article
by Wang, Zhaoming and Seow, Wei Jie and Shiraishi, Kouya and Hsiung, Chao A and Matsuo, Keitaro and Liu, Jie and Chen, Kexin and Yamji, Taiki and Yang, Yang and Chang, I.-Shou and Wu, Chen and Hong, Yun-Chul and Burdett, Laurie and Wyatt, Kathleen and Chung, Charles C and Li, Shengchao A and Yeager, Meredith and Hutchinson, Amy and Hu, Wei and Caporaso, Neil and Landi, Maria T and Chatterjee, Nilanjan and Song, Minsun and Fraumeni, Joseph F and Kohno, Takashi and Yokota, Jun and Kunitoh, Hideo and Ashikawa, Kyota and Momozawa, Yukihide and Daigo, Yataro and Mitsudomi, Tetsuya and Yatabe, Yasushi and Hida, Toyoaki and Hu, Zhibin and Dai, Juncheng and Ma, Hongxia and Jin, Guangfu and Song, Bao and Wang, Zhehai and Cheng, Sensen and Yin, Zhihua and Li, Xuelian and Ren, Yangwu and Guan, Peng and Chang, Jiang and Tan, Wen and Chen, Chien-Jen and Chang, Gee-Chen and Tsai, Ying-Huang and Su, Wu-Chou and Chen, Kuan-Yu and Huang, Ming-Shyan and Chen, Yuh-Min and Zheng, Hong and Li, Haixin and Cui, Ping and Guo, Huan and Xu, Ping and Liu, Li and Iwasaki, Motoki and Shimazu, Taichi and Tsugane, Shoichiro and Zhu, Junjie and Jiang, Gening and Fei, Ke and Park, Jae Yong and Kim, Yeul Hong and Sung, Jae Sook and Park, Kyong Hwa and Kim, Young Tae and Jung, Yoo Jin and Kang, Chang Hyun and Park, In Kyu and Kim, Hee Nam and Jeon, Hyo-Sung and Choi, Jin Eun and Choi, Yi Young and Kim, Jin Hee and Oh, In-Jae and Kim, Young-Chul and Sung, Sook Whan and Kim, Jun Suk and Yoon, Ho-Il and Kweon, Sun-Seog and Shin, Min-Ho and Seow, Adeline and Chen, Ying and Lim, Wei-Yen and Liu, Jianjun and Wong, Maria Pik and Lee, Victor Ho Fun and Bassig, Bryan A and Tucker, Margaret and Berndt, Sonja I and Chow, Wong-Ho and Ji, Bu-Tian and Wang, Junwen and Xu, Jun and Sihoe, Alan Dart Loon and Ho, James C.M and ...
Human Molecular Genetics, ISSN 0964-6906, 02/2016, Volume 25, Issue 3, pp. 620 - 629
Journal Article
by Seow, Wei Jie and Matsuo, Keitaro and Hsiung, Chao Agnes and Shiraishi, Kouya and Song, Minsun and NamKim, Hee and Wong, Maria Pik and Hong, Yun-Chul and Dean Hosgood, H and Wang, Zhaoming and Chang, I-Shou and Wang, Jiu-Cun and Chatterjee, Nilanjan and Tucker, Margaret and Wei, Hu and Mitsudomi, Tetsuya and Zheng, Wei and Kim, Jin Hee and Zhou, Baosen and Caporaso, Neil E and Albanes, Demetrius and Shin, Min-Ho and Chung, Lap Ping and An, She-Juan and Wang, Ping and Zheng, Hong and Yatabe, Yasushi and Zhang, Xu-Chao and Kim, Young Tae and Shu, Xiao-Ou and Kim, Young-Chul and Bassig, Bryan A and Chang, Jiang and Man Ho, James Chung and Ji, Bu-Tian and Kubo, Michiaki and Daigo, Yataro and Ito, Hidemi and Momozawa, Yukihide and Ashikawa, Kyota and Kamatani, Yoichiro and Honda, Takayuki and Sakamoto, Hiromi and Kunitoh, Hideo and Tsuta, Koji and Watanabe, Shun-Ichi and Nokihara, Hiroshi and Miyagi, Yohei and Nakayama, Haruhiko and Matsumoto, Shingo and Tsuboi, Masahiro and Goto, Koichi and Yin, Zhihua and Shi, Jianxin and Takahashi, Atsushi and Goto, Akiteru and Minamiya, Yoshihiro and Shimizu, Kimihiro and Tanaka, Kazumi and Wu, Tangchun and Wei, Fusheng and Wong, Jason Y.Y and Matsuda, Fumihiko and Su, Jian and Kim, Yeul Hong and Oh, In-Jae and Song, Fengju and Lee, Victor Ho Fun and Su, Wu-Chou and Chen, Yuh-Min and Chang, Gee-Chen and Chen, Kuan-Yu and Huang, Ming-Shyan and Yang, Pan-Chyr and Lin, Hsien-Chih and Xiang, Yong-Bing and Seow, Adeline and Park, Jae Yong and Kweon, Sun-Seog and Chen, Chien-Jen and Li, Haixin and Gao, Yu-Tang and Wu, Chen and Qian, Biyun and Lu, Daru and Liu, Jianjun and Jeon, Hyo-Sung and Hsiao, Chin-Fu and Sung, Jae Sook and Tsai, Ying-Huang and Jung, Yoo Jin and Guo, Huan and Hu, Zhibin and Wang, Wen-Chang and Chung, Charles C and Lawrence, Charles and Burdett, Laurie and Yeager, Meredith and Jacobs, Kevin B and Hutchinson, Amy and ...
Human Molecular Genetics, ISSN 0964-6906, 2017, Volume 26, Issue 2, pp. 454 - 465
Journal Article
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 09/2017, Volume 18, pp. S3 - S3
Anlotinib hydrochloride, an oral tyrosine kinase inhibitor targeting VEGFR, FGFR, PDGFR, and c-kit, showed promising efficacy in a phase 2 study. Here, we... 
ONCOLOGY | Lung cancer, Non-small cell | Vascular endothelial growth factor | Care and treatment | Tyrosine | Clinical trials
Journal Article
Journal Article
Cancer Management and Research, ISSN 1179-1322, 2018, Volume 10, pp. 3219 - 3226
Background: Few studies have focused on the role of surgery in the treatment of stage IV non-small cell lung cancer (NSCLC). In our study, we mainly focused on... 
Prognosis | Stage IV | Lung cancer | Surgery | SURVIVAL | MANAGEMENT | RESECTION | SINGLE-CENTER | prognosis | SYSTEMIC THERAPY | lung cancer | CELL LUNG-CANCER | SYNCHRONOUS BRAIN METASTASES | ONCOLOGY | stage IV | OUTCOMES | surgery | Care and treatment | Diagnosis | Lung cancer, Non-small cell | Epidemiology | Analysis | Thoracic surgery | Histology | Metastasis | Patients | Cancer therapies | Data bases | Studies | Brain research | Hospitals | Surveillance | Medical prognosis | Population | Age
Journal Article
OncoTargets and Therapy, ISSN 1178-6930, 2018, Volume 11, pp. 8421 - 8426
Background and objective: Several clinical trials have reported that intrapleural infusion of bevacizumab with or without cisplatin exhibits encouraging... 
NS-NSCLC | MPE | Pemetrexed | Bevacizumab | DIAGNOSIS | pemetrexed | ASCITES | PROGNOSTIC-FACTORS | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | VEGF